Reduced Adipose Tissue Macrophage Content Is Associated With Improved Insulin Sensitivity in Thiazolidinedione-Treated Diabetic Humans
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Obesity is associated with increased adipose tissue macrophage (ATM) infiltration, and rodent studies suggest that inflammatory factors produced by ATMs contribute to insulin resistance and type 2 diabetes. However, a relationship between ATM content and insulin resistance has not been clearly established in humans. Since thiazolidinediones attenuate adipose tissue inflammation and improve insulin sensitivity, we examined the temporal relationship of the effects of pioglitazone on these two parameters. The effect of 10 and 21 days of pioglitazone treatment on insulin sensitivity in 26 diabetic subjects was assessed by hyperinsulinemic-euglycemic clamp studies. Because chemoattractant factors, cytokines, and immune cells have been implicated in regulating the recruitment of ATMs, we studied their temporal relationship to changes in ATM content. Improved hepatic and peripheral insulin sensitivity was seen after 21 days of pioglitazone. We found early reductions in macrophage chemoattractant factors after only 10 days of pioglitazone, followed by a 69% reduction in ATM content at 21 days and reduced ATM activation at both time points. Although markers for dendritic cells and neutrophils were reduced at both time points, there were no significant changes in regulatory T cells. These results are consistent with an association between adipose macrophage content and systemic insulin resistance in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
Fat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085 · cited 1×
“In humans these receptors are most highly expressed in adipocytes (36), but are also present in other cells types, including macrophages (37,38).”
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 4×
“After 10 days of pioglitazone treatment, gene expression of IL-6 and IL-1b was decreased in whole fat, with a downward trend in TNF-a.”
InfluentialObesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · cited 1×
“Adipose tissue generates substantial amounts of proinflammatory molecules believed to contribute to insulin resistance (3).”
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Macrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.-L., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2277 · Cited by 1,164 · cited 2×
“Increased local production of macrophage chemoattractant protein-1 (MCP-1) appears to recruit circulating monocytes/macrophages through interaction with the MCP-1 receptor chemokine (C-C motif) receptor 2 (CCR2) (9–11), and MCP-1 expression is increased in human adipose tissue from obese subjects (6).”
Research works printed but not linked: 34
- Hedley, 2004, Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002, JAMA, 291, 2847, 10.1001/jama.291.23.2847 · DOI · Paper page
- Ogden, 2006, Prevalence of overweight and obesity in the United States, 1999-2004, JAMA, 295, 1549, 10.1001/jama.295.13.1549 · DOI · Paper page
- Makkonen, 2007, Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity, Int J Obes (Lond), 31, 1617, 10.1038/sj.ijo.0803635 · DOI
- Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
- Lagathu, 2006, Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes, Diabetologia, 49, 2162, 10.1007/s00125-006-0335-z · DOI · Paper page
- Féral, 2008, Blockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity, Diabetes, 57, 1842, 10.2337/db07-1751 · DOI · Paper page
- Oh, 2012, Increased macrophage migration into adipose tissue in obese mice, Diabetes, 61, 346, 10.2337/db11-0860 · DOI · Paper page
- Ortega Martinez de Victoria, 2009, Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians, Diabetes, 58, 385, 10.2337/db08-0536 · DOI · Paper page
- Tam, 2010, Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans, Diabetes, 59, 2164, 10.2337/db10-0162 · DOI · Paper page
- Boring, 1997, Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice, J Clin Invest, 100, 2552, 10.1172/JCI119798 · DOI · Paper page
- Han, 2007, Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion, Diabetes, 56, 2260, 10.2337/db07-0218 · DOI · Paper page
- Rocha, 2008, Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity, Circ Res, 103, 467, 10.1161/CIRCRESAHA.108.177105 · DOI · Paper page
- Trayhurn, 2001, Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ, Proc Nutr Soc, 60, 329, 10.1079/PNS200194 · DOI · Paper page
- Deiuliis, 2011, Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers, PLoS ONE, 6, e16376, 10.1371/journal.pone.0016376 · DOI · Paper page
- Eller, 2011, Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy, Diabetes, 60, 2954, 10.2337/db11-0358 · DOI · Paper page
- Zeyda, 2011, Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients, Obesity (Silver Spring), 19, 743, 10.1038/oby.2010.123 · DOI · Paper page
- Elgazar-Carmon, 2008, Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding, J Lipid Res, 49, 1894, 10.1194/jlr.M800132-JLR200 · DOI · Paper page
- Stefanovic-Racic, 2012, Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver, Diabetes, 61, 2330, 10.2337/db11-1523 · DOI · Paper page
- McCoy, 2012, Effect of insulin sensitizer therapy on atherothrombotic and inflammatory profiles associated with insulin resistance., 561
- Tonelli, 2004, Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes, Diabetes, 53, 1621, 10.2337/diabetes.53.6.1621 · DOI · Paper page
- Di Gregorio, 2005, Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone, Diabetes, 54, 2305, 10.2337/diabetes.54.8.2305 · DOI · Paper page
- Golay, 1988, Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp, Diabete Metab, 14, 443
- Kishore, 2011, Activation of K(ATP) channels suppresses glucose production in humans, J Clin Invest, 121, 4916, 10.1172/JCI58035 · DOI · Paper page
- Mauriège, 1999, Regional and gender variations in adipose tissue lipolysis in response to weight loss, J Lipid Res, 40, 1559, 10.1016/S0022-2275(20)33402-7 · DOI · Paper page
- Hawkins, 2002, Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects, Diabetes, 51, 2179, 10.2337/diabetes.51.7.2179 · DOI · Paper page
- Gordon, 2003, Alternative activation of macrophages, Nat Rev Immunol, 3, 23, 10.1038/nri978 · DOI · Paper page
- Klappacher, 2002, Roles of peroxisome proliferator-activated receptor gamma in lipid homeostasis and inflammatory responses of macrophages, Curr Opin Lipidol, 13, 305, 10.1097/00041433-200206000-00011 · DOI
- Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids, J Clin Invest, 99, 2416, 10.1172/JCI119424 · DOI · Paper page
- Castrillo, 2004, Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation, Annu Rev Cell Dev Biol, 20, 455, 10.1146/annurev.cellbio.20.012103.134432 · DOI · Paper page
- Lumeng, 2009, T-ing up inflammation in fat, Nat Med, 15, 846, 10.1038/nm0809-846 · DOI
- Mantovani, 2004, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol, 25, 677, 10.1016/j.it.2004.09.015 · DOI · Paper page
- Stout, 2005, Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences, 342
- Zhong, 2013, A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation, Diabetes, 62, 149, 10.2337/db12-0230 · DOI · Paper page
- Duffaut, 2009, Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity, Biochem Biophys Res Commun, 384, 482, 10.1016/j.bbrc.2009.05.002 · DOI · Paper page
Cited by
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“The inhibition of NF-κB pathway reduces ATM content (Esterson et al., 2013; Koppaka et al., 2013), restores the M2 macrophages phenotype (Chawla, 2010), and stimulates the recruitment of the anti-inflammatory regulatory T cells in the AT (Cipolletta et al., 2012).”
BackgroundRegulation of metabolism by the innate immune system
Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667
Insulin resistance and impaired adipogenesis
Gustafson, B., Hedjazifar, S., Gogg, S., Hammarstedt, A., & Smith, U. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.006 · Cited by 397
The “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation
Wensveen, F. M., Valentić, S., Šestan, M., Turk Wensveen, T., & Polić, B. (2015) · European Journal of Immunology · doi:10.1002/eji.201545502 · Cited by 348
The Role of the Immune System in Metabolic Health and Disease
Zmora, N., Bashiardes, S., Levy, M., & Elinav, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.006 · Cited by 323
“…shown to reduce adipose tissue inflammation, lower the number of ATMs, enhance the beneficial Treg activity, and increase adiponectin levels and FGF21, which improved lipid metabolism (Ahmadian et al., 2013; Cipolletta et al., 2012; Dutchak et al., 2012; Koppaka et al., 2013).”
BackgroundMacrophage functions in lean and obese adipose tissue
Thomas, D., & Apovian, C. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.005 · Cited by 316
Macrophage recruitment in obese adipose tissue
Bai, Y., & Sun, Q. (2015) · Obesity Reviews · doi:10.1111/obr.12242 · Cited by 280
Ito, D., Shimizu, S., Inoue, K., Saito, D., Yanagisawa, M., Inukai, K., Akiyama, Y., Morimoto, Y., Noda, M., & Shimada, A. (2017) · Diabetes Care · doi:10.2337/dc17-0518 · Cited by 279
Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity
Ramkhelawon, B., Hennessy, E. J., Ménager, M., Ray, T. D., Sheedy, F. J., Hutchison, S., Wanschel, A., Oldebeken, S., Geoffrion, M., Spiro, W., et al. (2014) · Nature Medicine · doi:10.1038/nm.3467 · Cited by 257
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“89 In the liver, in addition to the reduction of IHTG, thiazolidinediones promote the reduction of hepatic in fl ammation 78,79 and fi brosis, 90 also preventing the activation of hepatic stellate cells.”
The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
Palavicini, J. P., Chavez-Velazquez, A., Fourcaudot, M., Tripathy, D., Pan, M., Norton, L., DeFronzo, R. A., & Shannon, C. E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.784391 · Cited by 36
Metadata
- Authors
- Koppaka, S., Kehlenbrink, S., Carey, M., Li, W., Sanchez, E., Lee, D.-E., Lee, H., Chen, J., Carrasco, E., Kishore, P., Zhang, K., & Hawkins, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-05-17
- Volume
- 62
- Issue
- 6
- Pages
- 1843-1854
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2119651601
- Cited by
- 93
- References
- 9
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.